Blaise Lippa

1.2k total citations
22 papers, 771 citations indexed

About

Blaise Lippa is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Blaise Lippa has authored 22 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Blaise Lippa's work include Synthesis and biological activity (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cancer Treatment and Pharmacology (3 papers). Blaise Lippa is often cited by papers focused on Synthesis and biological activity (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cancer Treatment and Pharmacology (3 papers). Blaise Lippa collaborates with scholars based in United States, United Kingdom and Japan. Blaise Lippa's co-authors include Paul A. Wender, Michael F. T. Koehler, Gary Borzillo, Patrick G. Harran, Leroy B. Townsend, Zhijian Zhu, Cheol‐Min Park, John C. Drach, Kevin W. Hinkle and Jef K. De Brabander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cancer Research.

In The Last Decade

Blaise Lippa

22 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Blaise Lippa United States 13 427 394 195 136 108 22 771
Jessica J. Field New Zealand 12 440 1.0× 569 1.4× 166 0.9× 135 1.0× 314 2.9× 23 1.1k
Stephen T. Wrobleski United States 13 384 0.9× 196 0.5× 86 0.4× 68 0.5× 37 0.3× 16 555
Paul A. Renhowe United States 18 617 1.4× 412 1.0× 56 0.3× 76 0.6× 83 0.8× 26 891
David J. Witter United States 16 411 1.0× 890 2.3× 272 1.4× 109 0.8× 255 2.4× 19 1.1k
Laurent Ettouati France 11 311 0.7× 198 0.5× 108 0.6× 101 0.7× 124 1.1× 27 574
James E. Sheppeck United States 15 296 0.7× 313 0.8× 72 0.4× 33 0.2× 72 0.7× 24 628
Kristi Leonard United States 15 338 0.8× 253 0.6× 36 0.2× 59 0.4× 183 1.7× 24 699
Sukumar Sakamuri United States 13 330 0.8× 393 1.0× 116 0.6× 49 0.4× 154 1.4× 24 724
Janet L. Gunzner United States 17 1.1k 2.6× 530 1.3× 189 1.0× 226 1.7× 134 1.2× 20 1.5k
James E. Ray United States 13 326 0.8× 274 0.7× 94 0.5× 39 0.3× 81 0.8× 19 574

Countries citing papers authored by Blaise Lippa

Since Specialization
Citations

This map shows the geographic impact of Blaise Lippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blaise Lippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blaise Lippa more than expected).

Fields of papers citing papers by Blaise Lippa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blaise Lippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blaise Lippa. The network helps show where Blaise Lippa may publish in the future.

Co-authorship network of co-authors of Blaise Lippa

This figure shows the co-authorship network connecting the top 25 collaborators of Blaise Lippa. A scholar is included among the top collaborators of Blaise Lippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blaise Lippa. Blaise Lippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krumpoch, Megan, Huidong Chen, Lia Luus, et al.. (2022). 834 Integrin αvβ8 inhibitor improves immune checkpoint therapy in advanced ovarian cancer model and its activity can be monitored in blood. Regular and Young Investigator Award Abstracts. A871–A871. 1 indexed citations
2.
Reszka-Blanco, Natalia, Vinod Yadav, Megan Krumpoch, et al.. (2021). Abstract 1559: Inhibition of integrin αvβ8 enhances immune checkpoint induced anti-tumor immunity by acting across immunologic synapse in syngeneic models of breast cancer. Cancer Research. 81(13_Supplement). 1559–1559. 1 indexed citations
3.
Zhang, Xin, Jason B. Cross, Jan Antoinette C. Romero, et al.. (2018). In-silico guided discovery of novel CCR9 antagonists. Journal of Computer-Aided Molecular Design. 32(4). 573–582. 3 indexed citations
4.
Mesleh, Michael F., Jason B. Cross, Jing Zhang, et al.. (2016). Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB. Bioorganic & Medicinal Chemistry Letters. 26(4). 1314–1318. 52 indexed citations
5.
Zhang, Jing, Jan Antoinette C. Romero, Jennifer Goss, et al.. (2015). Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters. 25(17). 3661–3664. 15 indexed citations
6.
Lippa, Blaise, Gonghua Pan, Matthew S. Corbett, et al.. (2008). Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3359–3363. 64 indexed citations
7.
Lippa, Blaise, Goss S. Kauffman, Joel T. Arcari, et al.. (2007). The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 17(11). 3081–3086. 20 indexed citations
8.
Lippa, Blaise. (2007). Inhibitors of Akt Activity. Expert Opinion on Therapeutic Patents. 17(5). 577–581. 3 indexed citations
9.
Lippa, Blaise, Joel Morris, Matthew S. Corbett, et al.. (2006). Discovery of novel isothiazole inhibitors of the TrkA kinase: Structure–activity relationship, computer modeling, optimization, and identification of highly potent antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3444–3448. 36 indexed citations
10.
Borzillo, Gary & Blaise Lippa. (2005). The Hedgehog Signaling Pathway as a Target for Anticancer Drug Discovery. Current Topics in Medicinal Chemistry. 5(2). 147–157. 50 indexed citations
11.
Wender, Paul A., Jeremy L. Baryza, Chad Bennett, et al.. (2002). The Practical Synthesis of a Novel and Highly Potent Analogue of Bryostatin. Journal of the American Chemical Society. 124(46). 13648–13649. 130 indexed citations
12.
Zhu, Zhijian, Blaise Lippa, John C. Drach, & Leroy B. Townsend. (2000). Design, Synthesis, and Biological Evaluation of Tricyclic Nucleosides (Dimensional Probes) as Analogues of Certain Antiviral Polyhalogenated Benzimidazole Ribonucleosides. Journal of Medicinal Chemistry. 43(12). 2430–2437. 85 indexed citations
13.
Wender, Paul A. & Blaise Lippa. (2000). Synthesis and biological evaluation of bryostatin analogues: the role of the A-ring. Tetrahedron Letters. 41(7). 1007–1011. 27 indexed citations
14.
Wender, Paul A., Kevin W. Hinkle, Michael F. T. Koehler, & Blaise Lippa. (1999). The rational design of potential chemotherapeutic agents: Synthesis of bryostatin analogues. Medicinal Research Reviews. 19(5). 388–407. 59 indexed citations
15.
Wender, Paul A., et al.. (1999). Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes. Bioorganic & Medicinal Chemistry Letters. 9(12). 1687–1690. 12 indexed citations
16.
Wender, Paul A., Kevin W. Hinkle, Michael F. T. Koehler, & Blaise Lippa. (1999). The rational design of potential chemotherapeutic agents: Synthesis of bryostatin analogues. Medicinal Research Reviews. 19(5). 388–407. 1 indexed citations
17.
Zhu, Zhijian, Blaise Lippa, & Leroy B. Townsend. (1999). Synthesis and Regioselective Ribosylation of 6,7-Dichloroimidazo[4,5-b]quinolin-2-one. The Journal of Organic Chemistry. 64(11). 4159–4168. 3 indexed citations
18.
Wender, Paul A., Patrick G. Harran, Michael F. T. Koehler, et al.. (1998). The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1. Proceedings of the National Academy of Sciences. 95(12). 6624–6629. 83 indexed citations
19.
Wender, Paul A., Jef K. De Brabander, Patrick G. Harran, et al.. (1998). Synthesis and biological evaluation of fully synthetic bryostatin analogues. Tetrahedron Letters. 39(47). 8625–8628. 29 indexed citations
20.
Zhu, Zhijian, Blaise Lippa, & Leroy B. Townsend. (1996). A novel photo-assisted annulation reaction for the synthesis of 6,7-dichloroimidazo[4,5-b]quinolin-2-one. Tetrahedron Letters. 37(12). 1937–1940. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica J. Field Breakdown of academic impact, for papers by Stephen T. Wrobleski Breakdown of academic impact, for papers by Paul A. Renhowe Breakdown of academic impact, for papers by David J. Witter Breakdown of academic impact, for papers by Laurent Ettouati Breakdown of academic impact, for papers by James E. Sheppeck Breakdown of academic impact, for papers by Kristi Leonard Breakdown of academic impact, for papers by Sukumar Sakamuri Breakdown of academic impact, for papers by Janet L. Gunzner Breakdown of academic impact, for papers by James E. Ray
Rankless by CCL
2026